Type
. Electrochemical antigen-retrieval of formaldehyde fixed and paraffin-embedded archived leprosy skin biopsies. Journal of molecular histology. 2004;35(5):433-41.
Type
. Can leprosy be neutralized by year 2000?. JAMA. 1992;267(17):2289.
Type
. Foot care program for patients with leprosy also may prevent amputations in persons with diabetes. JAMA. 1992;267(17):2288.
Type
. Last USPHS leprosy hospital phasing out; research relocating to university. JAMA. 1992;267(17):2287.
Type
. Specificity of IgG subclass antibodies in different clinical manifestations of leprosy. Clinical and experimental immunology [Internet]. 1992;88(2):253-7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1554298/pdf/clinexpimmunol00049-0069.pdf
Type
. Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection. Infection and immunity [Internet]. 1992;60(5):1840-4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC257082/pdf/iai00029-0126.pdf
Type
. [Control of blindness in developing countries]. Nederlands tijdschrift voor geneeskunde. 1992;136(13):619-23.
Type
. Comment: Recent advances in the antimicrobial chemotherapy of leprosy. Leprosy review [Internet]. 1992;63(1):83-8. Available from: http://leprev.ilsl.br/pdfs/1992/v63n1/pdf/v63n1a16.pdf
Type
. Agranulocytosis during multidrug therapy (MDT) of leprosy. Leprosy review [Internet]. 1992;63(1):82-3. Available from: http://leprev.ilsl.br/pdfs/1992/v63n1/pdf/v63n1a15.pdf
Type
. Eight years of follow-up of paucibacillary patients treated with short-course regimens. Leprosy review [Internet]. 1992;63(1):80-2. Available from: http://leprev.ilsl.br/pdfs/1992/v63n1/pdf/v63n1a14.pdf